FT. MYERS, Fla., Dec. 15 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. announced today that Jack G. Spitz has been appointed Vice President of Laboratory Operations. Mr. Spitz will be responsible for managing all laboratory operational affairs of the Company.
Douglas VanOort, Chairman and Chief Executive Officer, stated, "We are very pleased to welcome Jack Spitz to NeoGenomics. Jack brings strong operating experience in specialized laboratory testing, including histopathology, dermatopathology, and genetic testing. His process management skills will be very helpful as we maintain the highest quality and service levels even as we continue our rapid growth."
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.
For more news and information on NeoGenomics, please visit www.IRGnews.com/coi/NGNM where you can find a fact sheet on the company, investor presentations, and more. Interested parties can also access additional investor relations material, including an investment profile and an equity research report, from Hawk Associates at http://www.hawkassociates.com or from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/.
CONTACT: NeoGenomics, Inc., Steven C. Jones, Director of Investor
Relations, +1-239-325-2001, sjones@neogenomics.org; Hawk Associates, Inc.,
Ms. Julie Marshall, +1-305-451-1888, neogenomics@hawkassociates.com; or The
Investor Relations Group, Investor Relations: Michael Crawford,
+1-212-825-3210, mcrawford@investorrelationsgroup.com; or Media Relations:
Janet Vasquez, +1-212-825-3210, jvasquez@investorrelationsgroup.com
Web site: http://www.neogenomics.org/
